Skip to content
Review Open access

Patient perspective on adjunctive treatment for early onset scoliosis.

Oct 2026 · Journal of Clinical Orthopaedics and Trauma · Vol 83, pp. 103630 · 0 citations · 14 references
Medicine

Abstract

Background Treating early onset scoliosis (EOS) presents unique and complex challenges due to patients' young age, high risk for progression, and complications with surgical treatment. The purpose of this study was to examine families' behavior and motivation in pursuing adjunctive treatments for EOS. Methods This was a cross-sectional multicenter study. Inclusion criteria: patients with a diagnosis of EOS. A questionnaire was given to patients' families during outpatient visits. Descriptive statistics and a Chi-square test were used for analysis. Questions included if any adjunctive treatments were used, reasons for use, and whether the respondent would use them again. Results 72 patients (mean age at diagnosis, 3.5 ± 3.5 years) from 4 pediatric centers participated in the study. 39 (54.2%) used at least one method of adjunctive treatment, resulting in a total of 72 adjunctive treatment instances. Among all participants, the most used adjunctive treatments were physical therapy (n = 32, 44.4%), shoe lift/insert (n = 12, 16.7%), massage (n = 8, 11.1%), Schroth (n = 4, 5.6%), chiropractic manipulation (n = 3, 4.2%), and cupping (n = 2, 2.8%). The most common response to open ended questions on motivation for pursuing adjunctive treatment was following the prescription or recommendation of a physical therapist or pediatrician (21.4%, n = 6), preventing curve progression (21.4%, n = 6), and managing pain or provide comfort (17.9%, n = 5). Of the 39 patients, 92.3% would choose to use adjunctive therapy again. Conclusions A majority of patients with EOS surveyed used adjunctive treatments. The most common treatments were physical therapy, shoe-lift and massage. Over 90% of families would choose to use adjunctive treatments again. Level of evidence II.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.